Science and Development Network
News, views and information about science, technology and the developing world
.jpg){kind=small}
.jpg){kind=spacer}
.jpg){kind=small}
Improving access to affordable drugs is a complex issue for developing countries that has been tackled in various ways, from strengthening national research infrastructure to compulsory licensing for generic drugs.
(Photo credit: Gary Hampton)
Opinions and Analysis
Research needed to tackle neglected disease uncertainties
The revised malaria death toll suggests a need for research into uncertainties in controlling neglected tropical diseases, says Mark Booth.
7 February 2012
|
EN
Source: New Statesman
Biomed Analysis: Learning from India's polio success
India's carefully targeted strategy against polio holds lessons for other countries, and for other diseases, argues Priya Shetty.
31 January 2012
|
EN
Redesign trials to integrate Asian, Western medicine
4 January 2012
|
EN
Source: Nature
Policy Briefs
Policies to tackle HIV/AIDS
Reducing the global burden of HIV/AIDS relies on increased funding, more research and targeted prevention strategies.
1 December 2009
|
EN
Source: Health Affairs
News and Features
Drug could hit two neglected diseases at once
A drug undergoing clinical trials for sleeping sickness could also treat leishmaniasis, say researchers who have tested it on mice.
6 February 2012
|
EN
Public-private push against neglected diseases unveiled
Unprecedented collaboration by drug firms, ambitious targets and more funds form part of a new fight against neglected tropical diseases.
Global warming may raise risk of Pacific fish poisoning
26 January 2012
|
EN
Areas with low malaria rates 'need mass vaccination'
25 January 2012
|
EN
